Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
157M
-
Shares change
-
+8.39M
-
Total reported value, excl. options
-
$4.95B
-
Value change
-
+$228M
-
Put/Call ratio
-
0.48
-
Number of buys
-
134
-
Number of sells
-
-128
-
Price
-
$31.66
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2021
323 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q1 2021.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 157M shares
of 334M outstanding shares and own 46.81% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (19.7M shares), VANGUARD GROUP INC (12.1M shares), FRANKLIN RESOURCES INC (9.01M shares), BlackRock Inc. (8.97M shares), PERCEPTIVE ADVISORS LLC (8.65M shares), Avoro Capital Advisors LLC (8M shares), WELLINGTON MANAGEMENT GROUP LLP (7.25M shares), ORBIMED ADVISORS LLC (6.65M shares), Nikko Asset Management Americas, Inc. (5.35M shares), and Sumitomo Mitsui Trust Holdings, Inc. (5.3M shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.